Skip to main content

Table 3 Reasons for change of anti-retroviral therapy regimens

From: Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon

Antiretroviral therapy regimens (number of participants who had regimen changed) and reasons for change of regimens Number of participants who had their regimens changed per categories of the reasons of change (%)a
Zidovudine + lamivudine + nevirapine (n = 43)
 Stock out 43 (100%)
Tenofovir + lamivudine + nevirapine (n = 20)
 Stock out 20 (100%)
Stavudine + lamivudine + nevirapine (n = 53)
 Stock out 39 (73.6%)
 Tuberculosis 4 (7.5%)
 Peripheral neuropathy 4 (7.5%)
 Lipodystrophy 3 (5.7%)
 Pregnancy 3 (5.7%)
Zidovudine + lamivudine + efavirenz (n = 10)
 Stock out 10 (100%)
Tenofovir + lamivudine + efavirenz (n = 2)
 Stock out 1 (50%)
 Anemia 1 (50%)
Tenofovir + emcitrabine + efavirenz (n = 1) 1
Stock out 1 (100%)
  1. aPercentages in parenthesis correspond to the number of participants who had their regimen changed per specific reason of change, as a proportion of the total number of people who had that regimen changed